Pharmacy Times

DECEMBER 10, 2023

The study results shine a light on the potential need for further policy changes that promote gender equity and bridge the gap in R01 funding awarded to female applicants.

130

130

Fierce Healthcare

DECEMBER 10, 2023

Growth in autism and intellectual & developmental disability (IDD) services is at an all-time high, according to | Autism services grew 49% year-over-year between Q1 and Q3 2023, compared to the same period in 2022. Demand is likely on an upward trajectory, the report predicted.

121

121

Pharmacy Times

DECEMBER 10, 2023

Median overall survival is set to be more than 2 years, which is more than double the overall survival of current frontline therapies.

146

146

Med Ed 101

DECEMBER 10, 2023

This article will discuss two of the three commonly used non-stimulant medications for the management of ADHD and ADHD-related symptoms. We will primarily focus on comparing clonidine versus guanfacine in pediatric patients. As pharmacies deal with shortages of more and more stimulant medications commonly used to treat ADHD in children, it may come up more […] The post Clonidine Versus Guanfacine: ADHD Management appeared first on Med Ed 101.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 10, 2023

He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.

131

131

Fierce Pharma

DECEMBER 10, 2023

Roche’s blood cancer portfolio is booming with new life thanks to the antibody-drug conjugate Polivy and bispecifics. | As Roche’s blood cancer portfolio booms with new life thanks to the antibody-drug conjugate Polivy and bispecifics, the company is offering a look at data for two combinations of those drugs that support two phase 3 trials in diffuse large B-cell lymphoma.

100

100

Roots Analysis

DECEMBER 10, 2023

ResMed has sold millions of magnetic CPAP masks since 2014 and received only five reports of serious harm related to the magnets, which were reported to authorities. Introduction to Magnetic CPAP Masks The medical devices domain is facing a wave of safety concerns as ResMed, a prominent manufacturer of continuous positive airway pressure (CPAP) machines, issues an urgent field safety notice regarding its magnetic masks.

FDA 45

FDA Labelling Communication 45

PharmExec

DECEMBER 10, 2023

Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.

52

52

The Guardian - Pharmaceutical Industry

DECEMBER 10, 2023

Proposed merger with smaller competitor Sigma and stock market listing would unlock billions of dollars for founders of discount pharmacy chain Chemist Warehouse Follow our Australia news live blog for latest updates Get our morning and afternoon news emails , free app or daily news podcast Chemist Warehouse will become a publicly traded company through a merger with Sigma Healthcare, creating a retailing giant and unlocking billions of dollars for the founders of the discount pharmacy chain.

43

43

Roots Analysis

DECEMBER 10, 2023

Introduction In the ever-evolving landscape of weight loss solutions, keto gummies and weight loss gummies have emerged as tantalizing options, promising to revolutionize the journey to a healthier, slimmer self. As the hype around these supplements continues to build, the pressing questions on everyone’s minds are: Do they really work, and are they safe?

FDA 40

FDA 40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for CSL here.

52

52

Roots Analysis

DECEMBER 10, 2023

Introduction In the ever-evolving landscape of medical advancements, a groundbreaking study conducted by Resonant, a Utah-based biotech company specializing in diagnostic tests for neurodegenerative diseases, is developing an Alzheimer’s blood test, a potential game-changer in the early detection of Alzheimer’s disease. The research suggests that a simple blood test could be the key to identifying Alzheimer’s several years before symptoms surface, offering a glimmer of hope for milli

FDA 40

FDA 40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for CSL here.

52

52

Roots Analysis

DECEMBER 10, 2023

Aya Healthcare strengthens its physician recruitment technology by acquiring Winnow AI, a move aimed at boosting its capabilities in the digital staffing sector. In a significant move poised to revolutionize healthcare recruitment, Aya Healthcare, a leading healthcare staffing and workforce solutions provider, has successfully acquired Winnow AI. The acquisition marks a strategic partnership between Aya Healthcare and SwitchPoint Ventures, the creator of Winnow AI, an innovative artificial intel

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.

40

40

PharmExec

DECEMBER 10, 2023

Another year in the books.

52

52

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.

40

40

Roots Analysis

DECEMBER 10, 2023

Novo Nordisk aims to employ insights from obesity drug research to proactively hinder the occurrence of weight gain. Introduction Novo Nordisk, the eminent Danish pharmaceutical giant, has embarked on a groundbreaking journey. While the demand for Novo Nordisk’s weight-loss and diabetes drugs has already propelled the company to the status of Europe’s largest, it now seeks to revolutionize the paradigm by preventing weight gain itself.

Communication 40

Communication 40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

52

52

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

52

52

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Lupin here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Lupin here.

40

40

Pharmaceutical Technology

DECEMBER 10, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.

40

40